| Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression P Barboro, N Ferrari, C Balbi Cancer letters 352 (2), 152-159, 2014 | 112 | 2014 |
| Differential expression of nuclear lamins in normal and cancerous prostate tissues R Coradeghini, P Barboro, A Rubagotti, F Boccardo, S Parodi, ... Oncology reports 15 (3), 609-613, 2006 | 96 | 2006 |
| Unraveling the organization of the internal nuclear matrix: RNA-dependent anchoring of NuMA to a lamin scaffold P Barboro, C D'Arrigo, A Diaspro, M Mormino, I Alberti, S Parodi, ... Experimental cell research 279 (2), 202-218, 2002 | 91 | 2002 |
| A combined proteomics and metabolomics approach to assess the effects of gold nanoparticles in vitro S Gioria, J Lobo Vicente, P Barboro, R La Spina, G Tomasi, P Urbán, ... Nanotoxicology 10 (6), 736-748, 2016 | 87 | 2016 |
| Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer P Barboro, E Repaci, A Rubagotti, S Salvi, S Boccardo, B Spina, M Truini, ... British journal of cancer 100 (10), 1608-1616, 2009 | 86 | 2009 |
| The condensation of chromatin in apoptotic thymocytes shows a specific structural change C Allera, G Lazzarini, E Patrone, I Alberti, P Barboro, P Sanna, A Melchiori, ... Journal of Biological Chemistry 272 (16), 10817-10822, 1997 | 77 | 1997 |
| Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β‐catenin signaling in prostate cancer cells M Ciarlo, R Benelli, O Barbieri, S Minghelli, P Barboro, C Balbi, N Ferrari International journal of cancer 131 (3), 582-590, 2012 | 74 | 2012 |
| Novel antivascular efficacy of metronomic docetaxel therapy in prostate cancer: hnRNP K as a player R Benelli, S Monteghirfo, C Balbi, P Barboro, N Ferrari International journal of cancer 124 (12), 2989-2996, 2009 | 59 | 2009 |
| The role of nuclear matrix proteins binding to matrix attachment regions (Mars) in prostate cancer cell differentiation P Barboro, E Repaci, C D’Arrigo, C Balbi PloS one 7 (7), e40617, 2012 | 57 | 2012 |
| An intranuclear frame for chromatin compartmentalization and higher‐order folding P Barboro, C D'Arrigo, M Mormino, R Coradeghini, S Parodi, E Patrone, ... Journal of cellular biochemistry 88 (1), 113-120, 2003 | 57 | 2003 |
| Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer I Alberti, P Barboro, M Barbesino, P Sanna, L Pisciotta, S Parodi, G Nicolò, ... Journal of Cellular Biochemistry 79 (3), 471-485, 2000 | 56 | 2000 |
| Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis P Barboro, A Rubagotti, P Orecchia, B Spina, M Truini, E Repaci, ... Analytical Cellular Pathology 30 (1), 13-26, 2008 | 53 | 2008 |
| The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer A Brizzolara, R Benelli, R Venè, P Barboro, A Poggi, F Tosetti, N Ferrari Cancer Letters 400, 9-17, 2017 | 40 | 2017 |
| Structural domains and conformational changes in nuclear chromatin: a quantitative thermodynamic approach by differential scanning calorimetry C Balbi, ML Abelmoschi, L Gogioso, S Parodi, P Barboro, B Cavazza, ... Biochemistry 28 (8), 3220-3227, 1989 | 36 | 1989 |
| Changes in the cytoskeletal and nuclear matrix proteins in rat hepatocyte neoplastic nodules in their relation to the process of transformation P Barboro, I Alberti, P Sanna, S Parodi, C Balbi, C Allera, E Patrone Experimental cell research 225 (2), 315-327, 1996 | 34 | 1996 |
| Role of circulating tumor cells (CTC), androgen receptor full length (AR-FL) and androgen receptor splice variant 7 (AR-V7) in a prospective cohort of castration-resistant … C Cattrini, A Rubagotti, L Zinoli, L Cerbone, E Zanardi, M Capaia, ... Cancers 11 (9), 1365, 2019 | 33 | 2019 |
| Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer N Ferrari, I Granata, M Capaia, M Piccirillo, MR Guarracino, R Venè, ... Cell Communication and Signaling 15, 1-14, 2017 | 31 | 2017 |
| Targeting androgen-independent pathways: new chances for patients with prostate cancer? C Cattrini, E Zanardi, G Vallome, A Cavo, L Cerbone, A Di Meglio, ... Critical Reviews in Oncology/Hematology 118, 42-53, 2017 | 31 | 2017 |
| A proteomic approach to investigate AuNPs effects in Balb/3T3 cells S Gioria, H Chassaigne, D Carpi, A Parracino, S Meschini, P Barboro, ... Toxicology letters 228 (2), 111-126, 2014 | 30 | 2014 |
| Sequence specific peptidomimetic molecules inhibitors of a protein–protein interaction at the helix 1 level of c‐Myc E Nieddu, A Melchiori, MP Pescarolo, L Bagnasco, B Biasotti, B Licheri, ... The FASEB journal 19 (6), 1-26, 2005 | 29 | 2005 |
Carlo CattriniOspedale Policlinico San Martino - GenovaVerified email at studenti.unige.it
